The 91探花 is proud to announce that 56 faculty and researchers who completed their work while at 91探花have been named on the list from Clarivate.

The annual list identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade. Their names are drawn from the publications that rank in the top 1% by citations for field and publication year in the .

Highly Cited Researchers demonstrate significant and broad influence in their fields of research. The total list includes 7,131 awards from more than 1,300 institutions in 60 countries and regions. This small fraction of the global researcher population contributes disproportionately to extending the frontiers of knowledge and contributing to innovations that make the world healthier, more sustainable and which drive societal impact, according to Clarivate.

The that determines the 鈥渨ho鈥檚 who鈥� of influential researchers is drawn from data and analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information at Clarivate.

The list below includes faculty and researchers whose primary affiliation is with the UW, Fred Hutch Cancer Center, and the Institute for Health Metrics and Evaluation.

Please note: Some of the people on the list are no longer with the 91探花and their current affiliation is noted. This list reflects initial data from Clarivate and may be updated.

Ivan Anishchenko (Vilya)

David Baker

William A. Banks

Gregory N. Bratman

Steven L. Brunton

Guozhong Cao

Ting Cao

Lauren Carter (Gates Medical Research Institute)

Helen Chu

David H. Cobden

Katharine H. D. Crawford

Riza M. Daza

Frank DiMaio

Kristie L. Ebi

Evan E. Eichler

Emmanuela Gakidou

David Ginger

Raphael Gottardo (CHUV)

Alexander L. Greninger

Simon I. Hay

Andrew Hill (Infinimmune)

Eric Huang

Michael C. Jensen (BrainChild)

Neil P.听 King

C. Dirk Keene

J. Nathan Kutz

Eric H. Larson

Aaron Lyon

Michael J. MacCoss

Brendan MacLean

C. M. Marcus

Julian D. Marshall

Ali Mokdad

Thomas J. Montine (Stanford)

Mohsen Naghavi

Marian L. Neuhouser

Julian D. Olden

Robert W. Palmatier

David Pigott

Hannah A. Pliner (Bristol Myers Squibb)

Ganesh Raghu

Stanley Riddell

Andrea Schietinger (Memorial Sloan Kettering Cancer Center)

Jay Shendure

M. Alejandra Tortorici

Troy R. Torgerson (Allen Institute)

Cole Trapnell

Katherine R. Tuttle

David Veesler

Theo Vos

Alexandra C. Walls (BioNTech SE)

Bryan J. Weiner

Di Xiao

Jie Xiao

Xiaodong Xu

Jihui Yang

The 91探花 is proud to announce that more than 40 faculty and researchers who completed their work while at 91探花have been named on the annual list from Clarivate.

The annual list identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade. Their names are drawn from the publications that rank in the top 1% by citations for field and publication year in the Web of Science citation index.

The list of faculty and researchers whose primary affiliation is with the 91探花or with the Institute for Health Metrics and Evaluation who were acknowledged for their work includes:

David Baker

William A. Banks

Gregory N. Bratman

Steven L. Brunton

Guozhong Cao

William A. Catterall

Helen Chu

David H. Cobden

Katharine H.D. Crawford

Riza M. Daza

Frank DiMaio

Evan E. Eichler

Michael Gale Jr.

Raphael Gottardo

Allison J. Greaney

Alexander L. Greninger

Simon I. Hay

Celestia S. Higano

Neil P. King

James B. Leverenz

Charles M. Marcus

Philip Mease

Ali Mokdad

Thomas J. Montine*

Christopher J. L. Murray

Mohsen Naghavi

William S. Noble

Young-Jun Park

David M. Pigott

Stanley Riddell

Andrea Schietinger **

Jay Shendure

M. Alejandra Tortorici

Troy R. Torgerson***

Cole Trapnell

David Veesler

Theo Vos

Alexandra C. Walls****

Bryan J. Weiner

Spencer A. Wood

Sanfeng Wu

Di Xiao

Xiaodong Xu

The that determines the 鈥渨ho鈥檚 who鈥� of influential researchers draws on the data and analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information at Clarivate. It also uses the tallies to identify the countries and research institutions where these scientific elite are based.

The full 2023 Highly Cited Researchers list and executive summary can be found online .

* now is at Stanford University.

** now is at Memorial Sloan Kettering Cancer Center.

*** now is at the Allen Institute.

**** now is at BoiNTech SE.

now is at Princeton University.

To better identify and prevent future pandemics, the 91探花 has become a partner in a five-year global, collaborative agreement with the U.S. Agency for International Development. The newly launched Discovery & Exploration of Emerging Pathogens – Viral Zoonoses, or DEEP VZN project, has approximately $125 million in anticipated funding and will be led by Washington State University.

The effort will build scientific capacity in partner countries to safely detect and characterize viruses which have the potential to spill over from wildlife and domestic animals to human populations.

“The DEEP VZN project provides an exciting chance to better understand why the world is experiencing more frequent and severe outbreaks of zoonotic infectious diseases transmitted between animals and people,鈥� said Dr. , a co-principal investigator for USAID DEEP VZN and professor of environmental and occupational health sciences in the 91探花School of Public Health.

鈥淭his means gaining knowledge about new viruses that could cause problems in the future, and the ecosystem changes that appear to be driving the process of viruses jumping between species,鈥� Rabinowitz added. 鈥淭丑别 hope is that this improved understanding will lead to prevention of future pandemics and more resilient ecosystems.鈥�

Rabinowitz is also director of the and co-director of the .

The project plans to initially partner with five countries in Africa, Asia and Latin America to help local organizations carry out large-scale animal surveillance programs within their own countries safely and test samples for viruses using their own laboratory facilities. This will avoid the process of having to ship samples to other countries for testing and build an international network of laboratories capable of quickly responding to disease outbreaks.

鈥淪ince the vast majority of viruses that ignite pandemics have their origin in nonhuman animals, it is critical that we figure out which of the many new zoonotic viruses that we are now identifying are most likely to jump species into humans, spread easily from person to person and cause severe disease or death,鈥� said Dr. , a co-principal investigator in the project and chair of the 91探花Department of Global health.

鈥淭丑别 focuses on a proactive, integrated systems approach to pandemic preparedness that has brought together internationally recognized leaders in the kinds of laboratory methods that will make it possible for the DEEP VZN team to fully sequence and characterize novel viruses in unprecedented breadth and depth,鈥� said Wasserheit, co-director of the Alliance. 鈥淚n addition, the Alliance鈥檚 approach catalyzed collaborations between these lab-based scientists; One Health leaders working at the interface of human, animal and environmental health; and leaders in Global Health who will work with colleagues in focus countries to identify high-risk locations and subpopulations at the human-animal interface.鈥�

The DEEP VZN project will focus on finding previously unknown pathogens from three viral families that have a large potential for viral spillover from animals to humans: coronaviruses, the family that includes SARS-CoV-2, the virus that causes COVID-19; filoviruses, like Ebola virus; and paramyxoviruses, such as Nipah virus. With 70% of new viral outbreaks in people originating from animals, understanding future threats helps protect the U.S. as well as the partner countries.

The goals are ambitious: to collect over 800,000 samples in the five years of the project, most of which will come from wildlife; then to detect whether known and novel viruses from the target families are present in the samples. When those are found, the researchers will determine their zoonotic potential, or the ability to be transmitted between animals and humans.

This process is expected to yield 8,000 to 12,000 novel viruses, which researchers will then screen and genome sequence for the ones that pose the most risk to animal and human health.

The UW聽Medicine聽laboratory effort, led by聽Dr.听Alex Greninger,聽assistant professor of laboratory medicine and pathology at 91探花 School of Medicine, will use聽the聽cutting-edge research expertise of five internationally recognized 91探花Medicine laboratories to聽develop innovative techniques and provide reference and support activities for virus detection and characterization by in-country labs.

鈥淚t鈥檚 time to get to work and find some new viruses. We will be building capacity in other countries to be able to find new viruses and characterize them in hopes to better understand coronaviruses and other viruses circulating in the world,鈥� said Greninger.

The 91探花Medicine labs:

• The will coordinate聽qRT-PCR and broad serology assay development and in-country training, viral genome recovery and viral glycoprotein characterization.
• The David will model novel viral glycoproteins to determine risk potential based on in silico screens for potential human receptor affinity.
• 罢丑别听顿补惫颈诲 has detailed mechanisms of viral attachment and entry for novel paramyxoviruses and coronaviruses and will extend these biochemical studies to novel viral glycoproteins discovered in DV.
• will determine the degree and mechanisms of innate immunity evasion in human cells by novel viruses.
• The will produce recombinant proteins for in-country serological analysis as it has done for SARS-CoV-2.

The 91探花Department of Global Health will apply its experience in more than 145 countries and expertise in capacity strengthening through the International Training and Education Center for Health, or I-TECH, to support sustainable sampling and strengthen in-country laboratory programs.

In addition to 91探花and WSU, USAID DEEP VZN includes virology expertise of The Washington University at St. Louis, as well as data management and in-country expertise of public health nonprofits PATH, based in Seattle, and FHI 360, based in North Carolina. These partners have extensive established presence and partners in countries in the target regions.

鈥淭o make sure the world is better prepared for these infectious disease events, which are likely to happen more frequently as wild areas become increasingly fragmented, we need to be ready,鈥� said Felix Lankester, lead principal investigator for USAID DEEP VZN and associate professor with WSU鈥檚 Paul G. Allen School for Global Health. 鈥淲e will work to not only detect viruses but also build capacity in other countries, so the United States can collaborate with them in carrying out this important work.鈥�

###

For more information, contact Jake Ellison at Jbe3@uw.edu

This story was adapted from a Washington State University .听